Just What the Doctor Ordered
This is a quick update on Kemp Dolliver's previous insight "Who's Optimistic About Pharmacy's Future in China? China Nepstar's Controlling...
297 Views
Coming to the HKEX Soon....................
Bloomberg has published a story (that others have cited) that WuXi Pharmatech has picked bankers for an HK listing of its biologics manufacturing...
223 Views
Time to Go Shopping for Healthcare
The decline in equity markets has created opportunities to buy a variety of healthcare stocks at attractive valuations. Insider purchases have...
248 Views
China's FDA Ups Its Game
One of the pharmaceutical industry’s main complaints about China is the extremely slow drug approval process. The approval process in China...
306 Views
QUICKNOTE: H1 Results in Line, R&D Pipeline Expands
3SBio, China's leading biotech company, posted H1 results in line with pre-deal expectations. The recent acquisition of Zhejiang Wansheng broadens...
274 Views